Production (Stage)
Inspire Medical Systems, Inc.
INSP
$143.21
-$2.74-1.88%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -91.51% | 90.43% | 88.88% | 197.88% | -167.77% |
| Total Depreciation and Amortization | 22.84% | 33.95% | 33.77% | 64.84% | 2.69% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.09% | 8.07% | -13.31% | 31.80% | 6.43% |
| Change in Net Operating Assets | -1,498.04% | -45.33% | 113.67% | -738.53% | 75.11% |
| Cash from Operations | -109.69% | 32.32% | 67,129.49% | -100.88% | -48.69% |
| Capital Expenditure | -19.64% | 12.24% | 35.39% | -5.96% | -45.60% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -36.47% | 111.36% | -627.18% | 329.79% | 94.54% |
| Cash from Investing | -141.29% | 103.65% | -1,932.17% | 128.77% | 87.12% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 555.91% | -93.10% | 58.96% | 147.48% | -5.09% |
| Repurchase of Common Stock | -32.45% | -1,540.60% | -132.81% | 34.62% | 79.55% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -25.12% | -809.18% | 39.55% | 822.79% | 107.59% |
| Foreign Exchange rate Adjustments | -51.81% | -161.03% | 2,820.00% | 95.33% | -201.42% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3,749.28% | 106.51% | -421.13% | 224.68% | 92.99% |